Research Peptides
A high-purity research peptide studied in cognitive and neuroprotection research. Available in 5mg and 10mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in cognitive and neuroprotection research. Available in 5mg and 10mg, with every batch independently tested and dispatched from the UK.
Semax peptide UK is Crown Peptides' synthetic peptide derived from an ACTH fragment, supplied in 5mg and 10mg vials for laboratory research into BDNF signalling, neuronal plasticity and cognition.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Semax is a synthetic peptide developed from the ACTH(4-7) fragment with an added Pro-Gly-Pro sequence. It is studied in neurobiology because its research profile differs substantially from full-length ACTH and centres on neurotrophic, neuronal and stress-response pathways.
Semax research includes BDNF and other neurotrophic signalling, neuronal plasticity, learning and memory models, oxidative-stress responses and experimental neuroprotection (Learn more). Studies have also examined gene-expression and neurotransmitter changes following peptide exposure, alongside related nootropic and neuro-research peptides such as [Selank] and [DSIP]. These areas make Semax a frequently discussed compound in laboratory research on adaptive neuronal signalling.
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides Semax is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification. The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with Semax may also be interested in [Selank], [DSIP], [VIP], [Epitalon] and [Kisspeptin-10] — other neuro and signalling-research peptides studied in related research areas.
Semax is a synthetic peptide derived from the ACTH(4-7) sequence with a Pro-Gly-Pro extension, supplied by Crown Peptides in 5mg and 10mg vials.
Research includes neurotrophic signalling, cognition, neuronal plasticity, oxidative stress and neuroprotection models.
No. It is a short synthetic fragment-derived peptide and does not represent full-length ACTH.
Several experimental studies have examined changes in BDNF and other neurotrophic signalling pathways following Semax exposure.
Peptide purity and molecular identity can be assessed using HPLC and Mass Spectrometry, with exact batch results shown on the CoA.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.